Global Antifungal Susceptibility Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Antifungal Susceptibility Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Antifungal susceptibility testing is a laboratory method used to determine the effectiveness of antifungal drugs against fungal pathogens. It helps in guiding the selection of appropriate antifungal therapy for the treatment of fungal infections.
Antifungal Susceptibility Testing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antifungal Susceptibility Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Medical and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antifungal Susceptibility Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Antifungal Susceptibility Testing key companies include Bio Rad, Etest, ATCC, Ganesh Diagnostic, Ridacom, EWC Diagnostics, Etest and CLSI, etc. Bio Rad, Etest, ATCC are top 3 players and held % share in total in 2022.
Antifungal Susceptibility Testing can be divided into Antifungal Susceptibility Testing for Diagnostics and Antifungal Susceptibility Testing for Research, etc. Antifungal Susceptibility Testing for Diagnostics is the mainstream product in the market, accounting for % share globally in 2022.
Antifungal Susceptibility Testing is widely used in various fields, such as Medical, Scientific Research and Others,, etc. Medical provides greatest supports to the Antifungal Susceptibility Testing industry development. In 2022, global % share of Antifungal Susceptibility Testing went into Medical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Antifungal Susceptibility Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Bio Rad
Etest
ATCC
Ganesh Diagnostic
Ridacom
EWC Diagnostics
Etest
CLSI
Segment by Type
Antifungal Susceptibility Testing for Diagnostics
Antifungal Susceptibility Testing for Research
Medical
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antifungal Susceptibility Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antifungal Susceptibility Testing introduction, etc. Antifungal Susceptibility Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Antifungal Susceptibility Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Antifungal Susceptibility Testing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antifungal Susceptibility Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Medical and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antifungal Susceptibility Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Antifungal Susceptibility Testing key companies include Bio Rad, Etest, ATCC, Ganesh Diagnostic, Ridacom, EWC Diagnostics, Etest and CLSI, etc. Bio Rad, Etest, ATCC are top 3 players and held % share in total in 2022.
Antifungal Susceptibility Testing can be divided into Antifungal Susceptibility Testing for Diagnostics and Antifungal Susceptibility Testing for Research, etc. Antifungal Susceptibility Testing for Diagnostics is the mainstream product in the market, accounting for % share globally in 2022.
Antifungal Susceptibility Testing is widely used in various fields, such as Medical, Scientific Research and Others,, etc. Medical provides greatest supports to the Antifungal Susceptibility Testing industry development. In 2022, global % share of Antifungal Susceptibility Testing went into Medical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Antifungal Susceptibility Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Bio Rad
Etest
ATCC
Ganesh Diagnostic
Ridacom
EWC Diagnostics
Etest
CLSI
Segment by Type
Antifungal Susceptibility Testing for Diagnostics
Antifungal Susceptibility Testing for Research
Segment by Application
Medical
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antifungal Susceptibility Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antifungal Susceptibility Testing introduction, etc. Antifungal Susceptibility Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Antifungal Susceptibility Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.